Loading…
Pharmacokinetics, safety, and tolerability of a rapid infusion of i.v. ibuprofen in healthy adults
The pharmacokinetics, safety, and tolerability of a rapid infusion of i.v. ibuprofen in healthy adults were evaluated. Methods In this randomized, double-blind, placebo-controlled, single-dose, crossover study, 12 healthy subjects age 18-65 years were randomized to receive a single dose of either 80...
Saved in:
Published in: | American journal of health-system pharmacy 2011-01, Vol.68 (1), p.47-51 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c353t-58e2fa6d7a17f8ca2c0ca888c214a7721f792ad81b54ca0ef6bcbdb8b72c74e33 |
---|---|
cites | cdi_FETCH-LOGICAL-c353t-58e2fa6d7a17f8ca2c0ca888c214a7721f792ad81b54ca0ef6bcbdb8b72c74e33 |
container_end_page | 51 |
container_issue | 1 |
container_start_page | 47 |
container_title | American journal of health-system pharmacy |
container_volume | 68 |
creator | Pavliv, Leo Voss, Bryan Rock, Amy |
description | The pharmacokinetics, safety, and tolerability of a rapid infusion of i.v. ibuprofen in healthy adults were evaluated. Methods In this randomized, double-blind, placebo-controlled, single-dose, crossover study, 12 healthy subjects age 18-65 years were randomized to receive a single dose of either 800 mg i.v. ibuprofen (infused over five to seven minutes) concomitantly with an oral placebo or 800 mg oral ibuprofen with concomitant i.v. placebo (0.9% sodium chloride injection). After a six-day washout period, subjects received the treatment not previously received. Blood samples were taken 1 hour before each dose of study medication was administered and throughout the 12 hours thereafter. Plasma ibuprofen concentrations were determined using validated liquid chromatography-tandem mass spectrometry methods. The frequency and severity of treatment-emergent adverse effects were monitored throughout the study.
The maximum plasma concentration (C(max)) of i.v. ibuprofen was approximately twice that of oral ibuprofen, and the (t(max)) of i.v. ibuprofen was 0.11 hour, compared with 1.5 hours for oral ibuprofen. However, the elimination half-life of i.v. and oral ibuprofen did not differ, both of which were approximately 2 hours. Oral ibuprofen was 100% bioavailable; therefore, the area under the concentration-time curve did not differ between i.v. and oral ibuprofen. In addition, i.v. ibuprofen infused over five to seven minutes did not differ in terms of safety or tolerability when compared with oral ibuprofen.
I.V. ibuprofen, when administered over five to seven minutes in healthy subjects, achieved a higher C(max) and a more-rapid t(max) than did oral ibuprofen and was found to be safe and well tolerated. |
doi_str_mv | 10.2146/ajhp100120 |
format | article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_818644592</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A249137908</galeid><sourcerecordid>A249137908</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-58e2fa6d7a17f8ca2c0ca888c214a7721f792ad81b54ca0ef6bcbdb8b72c74e33</originalsourceid><addsrcrecordid>eNptkU1rHDEMhk1IaZJtL_kBxZBDIGS2tufDnuMSkrYQSA7JeZA9ctfJzHhrewL77-tlNy2FooPEq0dC4iXknLOl4FXzFV7WG84YF-yInPK6rAvRMnacaybbQjAlTshZjC87RLHmIzkRnDcVa-pToh_XEEYw_tVNmJyJ1zSCxbS9pjD1NPkBA2g3uLSl3lKgATaup26yc3R-2mlu-bakTs-b4C1OuUXXCENabyn085DiJ_LBwhDx8yEvyPPd7dPN9-L-4duPm9V9Ycq6TEWtUFhoeglcWmVAGGZAKWXyjyCl4Fa2AnrFdV0ZYGgbbXSvlZbCyArLckEu93vzIb9mjKkbXTQ4DDChn2OnuGqqqm5FJi_25E8YsMu_-BTA7OhuJaqWl7JlKlPL_1A5ehyd8RNal_V_Bq72Ayb4GAPabhPcCGHbcdbtnOr-OpXhL4drZz1i_wd9t6b8Dbx2jiM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>818644592</pqid></control><display><type>article</type><title>Pharmacokinetics, safety, and tolerability of a rapid infusion of i.v. ibuprofen in healthy adults</title><source>Oxford Journals Online</source><creator>Pavliv, Leo ; Voss, Bryan ; Rock, Amy</creator><creatorcontrib>Pavliv, Leo ; Voss, Bryan ; Rock, Amy</creatorcontrib><description>The pharmacokinetics, safety, and tolerability of a rapid infusion of i.v. ibuprofen in healthy adults were evaluated. Methods In this randomized, double-blind, placebo-controlled, single-dose, crossover study, 12 healthy subjects age 18-65 years were randomized to receive a single dose of either 800 mg i.v. ibuprofen (infused over five to seven minutes) concomitantly with an oral placebo or 800 mg oral ibuprofen with concomitant i.v. placebo (0.9% sodium chloride injection). After a six-day washout period, subjects received the treatment not previously received. Blood samples were taken 1 hour before each dose of study medication was administered and throughout the 12 hours thereafter. Plasma ibuprofen concentrations were determined using validated liquid chromatography-tandem mass spectrometry methods. The frequency and severity of treatment-emergent adverse effects were monitored throughout the study.
The maximum plasma concentration (C(max)) of i.v. ibuprofen was approximately twice that of oral ibuprofen, and the (t(max)) of i.v. ibuprofen was 0.11 hour, compared with 1.5 hours for oral ibuprofen. However, the elimination half-life of i.v. and oral ibuprofen did not differ, both of which were approximately 2 hours. Oral ibuprofen was 100% bioavailable; therefore, the area under the concentration-time curve did not differ between i.v. and oral ibuprofen. In addition, i.v. ibuprofen infused over five to seven minutes did not differ in terms of safety or tolerability when compared with oral ibuprofen.
I.V. ibuprofen, when administered over five to seven minutes in healthy subjects, achieved a higher C(max) and a more-rapid t(max) than did oral ibuprofen and was found to be safe and well tolerated.</description><identifier>ISSN: 1079-2082</identifier><identifier>EISSN: 1535-2900</identifier><identifier>DOI: 10.2146/ajhp100120</identifier><identifier>PMID: 21164065</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Administration, Oral ; Adult ; Anti-Inflammatory Agents, Non-Steroidal - administration & dosage ; Anti-Inflammatory Agents, Non-Steroidal - adverse effects ; Anti-Inflammatory Agents, Non-Steroidal - blood ; Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics ; Cross-Over Studies ; Dosage and administration ; Double-Blind Method ; Drug tolerance ; Female ; Gas Chromatography-Mass Spectrometry ; Half-Life ; Humans ; Ibuprofen ; Ibuprofen - administration & dosage ; Ibuprofen - adverse effects ; Ibuprofen - blood ; Ibuprofen - pharmacokinetics ; Infusions, Intravenous ; Male ; Pharmacokinetics</subject><ispartof>American journal of health-system pharmacy, 2011-01, Vol.68 (1), p.47-51</ispartof><rights>COPYRIGHT 2011 Oxford University Press</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-58e2fa6d7a17f8ca2c0ca888c214a7721f792ad81b54ca0ef6bcbdb8b72c74e33</citedby><cites>FETCH-LOGICAL-c353t-58e2fa6d7a17f8ca2c0ca888c214a7721f792ad81b54ca0ef6bcbdb8b72c74e33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21164065$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pavliv, Leo</creatorcontrib><creatorcontrib>Voss, Bryan</creatorcontrib><creatorcontrib>Rock, Amy</creatorcontrib><title>Pharmacokinetics, safety, and tolerability of a rapid infusion of i.v. ibuprofen in healthy adults</title><title>American journal of health-system pharmacy</title><addtitle>Am J Health Syst Pharm</addtitle><description>The pharmacokinetics, safety, and tolerability of a rapid infusion of i.v. ibuprofen in healthy adults were evaluated. Methods In this randomized, double-blind, placebo-controlled, single-dose, crossover study, 12 healthy subjects age 18-65 years were randomized to receive a single dose of either 800 mg i.v. ibuprofen (infused over five to seven minutes) concomitantly with an oral placebo or 800 mg oral ibuprofen with concomitant i.v. placebo (0.9% sodium chloride injection). After a six-day washout period, subjects received the treatment not previously received. Blood samples were taken 1 hour before each dose of study medication was administered and throughout the 12 hours thereafter. Plasma ibuprofen concentrations were determined using validated liquid chromatography-tandem mass spectrometry methods. The frequency and severity of treatment-emergent adverse effects were monitored throughout the study.
The maximum plasma concentration (C(max)) of i.v. ibuprofen was approximately twice that of oral ibuprofen, and the (t(max)) of i.v. ibuprofen was 0.11 hour, compared with 1.5 hours for oral ibuprofen. However, the elimination half-life of i.v. and oral ibuprofen did not differ, both of which were approximately 2 hours. Oral ibuprofen was 100% bioavailable; therefore, the area under the concentration-time curve did not differ between i.v. and oral ibuprofen. In addition, i.v. ibuprofen infused over five to seven minutes did not differ in terms of safety or tolerability when compared with oral ibuprofen.
I.V. ibuprofen, when administered over five to seven minutes in healthy subjects, achieved a higher C(max) and a more-rapid t(max) than did oral ibuprofen and was found to be safe and well tolerated.</description><subject>Administration, Oral</subject><subject>Adult</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - administration & dosage</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - adverse effects</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - blood</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics</subject><subject>Cross-Over Studies</subject><subject>Dosage and administration</subject><subject>Double-Blind Method</subject><subject>Drug tolerance</subject><subject>Female</subject><subject>Gas Chromatography-Mass Spectrometry</subject><subject>Half-Life</subject><subject>Humans</subject><subject>Ibuprofen</subject><subject>Ibuprofen - administration & dosage</subject><subject>Ibuprofen - adverse effects</subject><subject>Ibuprofen - blood</subject><subject>Ibuprofen - pharmacokinetics</subject><subject>Infusions, Intravenous</subject><subject>Male</subject><subject>Pharmacokinetics</subject><issn>1079-2082</issn><issn>1535-2900</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNptkU1rHDEMhk1IaZJtL_kBxZBDIGS2tufDnuMSkrYQSA7JeZA9ctfJzHhrewL77-tlNy2FooPEq0dC4iXknLOl4FXzFV7WG84YF-yInPK6rAvRMnacaybbQjAlTshZjC87RLHmIzkRnDcVa-pToh_XEEYw_tVNmJyJ1zSCxbS9pjD1NPkBA2g3uLSl3lKgATaup26yc3R-2mlu-bakTs-b4C1OuUXXCENabyn085DiJ_LBwhDx8yEvyPPd7dPN9-L-4duPm9V9Ycq6TEWtUFhoeglcWmVAGGZAKWXyjyCl4Fa2AnrFdV0ZYGgbbXSvlZbCyArLckEu93vzIb9mjKkbXTQ4DDChn2OnuGqqqm5FJi_25E8YsMu_-BTA7OhuJaqWl7JlKlPL_1A5ehyd8RNal_V_Bq72Ayb4GAPabhPcCGHbcdbtnOr-OpXhL4drZz1i_wd9t6b8Dbx2jiM</recordid><startdate>20110101</startdate><enddate>20110101</enddate><creator>Pavliv, Leo</creator><creator>Voss, Bryan</creator><creator>Rock, Amy</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20110101</creationdate><title>Pharmacokinetics, safety, and tolerability of a rapid infusion of i.v. ibuprofen in healthy adults</title><author>Pavliv, Leo ; Voss, Bryan ; Rock, Amy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-58e2fa6d7a17f8ca2c0ca888c214a7721f792ad81b54ca0ef6bcbdb8b72c74e33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Administration, Oral</topic><topic>Adult</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - administration & dosage</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - adverse effects</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - blood</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics</topic><topic>Cross-Over Studies</topic><topic>Dosage and administration</topic><topic>Double-Blind Method</topic><topic>Drug tolerance</topic><topic>Female</topic><topic>Gas Chromatography-Mass Spectrometry</topic><topic>Half-Life</topic><topic>Humans</topic><topic>Ibuprofen</topic><topic>Ibuprofen - administration & dosage</topic><topic>Ibuprofen - adverse effects</topic><topic>Ibuprofen - blood</topic><topic>Ibuprofen - pharmacokinetics</topic><topic>Infusions, Intravenous</topic><topic>Male</topic><topic>Pharmacokinetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pavliv, Leo</creatorcontrib><creatorcontrib>Voss, Bryan</creatorcontrib><creatorcontrib>Rock, Amy</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of health-system pharmacy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pavliv, Leo</au><au>Voss, Bryan</au><au>Rock, Amy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacokinetics, safety, and tolerability of a rapid infusion of i.v. ibuprofen in healthy adults</atitle><jtitle>American journal of health-system pharmacy</jtitle><addtitle>Am J Health Syst Pharm</addtitle><date>2011-01-01</date><risdate>2011</risdate><volume>68</volume><issue>1</issue><spage>47</spage><epage>51</epage><pages>47-51</pages><issn>1079-2082</issn><eissn>1535-2900</eissn><abstract>The pharmacokinetics, safety, and tolerability of a rapid infusion of i.v. ibuprofen in healthy adults were evaluated. Methods In this randomized, double-blind, placebo-controlled, single-dose, crossover study, 12 healthy subjects age 18-65 years were randomized to receive a single dose of either 800 mg i.v. ibuprofen (infused over five to seven minutes) concomitantly with an oral placebo or 800 mg oral ibuprofen with concomitant i.v. placebo (0.9% sodium chloride injection). After a six-day washout period, subjects received the treatment not previously received. Blood samples were taken 1 hour before each dose of study medication was administered and throughout the 12 hours thereafter. Plasma ibuprofen concentrations were determined using validated liquid chromatography-tandem mass spectrometry methods. The frequency and severity of treatment-emergent adverse effects were monitored throughout the study.
The maximum plasma concentration (C(max)) of i.v. ibuprofen was approximately twice that of oral ibuprofen, and the (t(max)) of i.v. ibuprofen was 0.11 hour, compared with 1.5 hours for oral ibuprofen. However, the elimination half-life of i.v. and oral ibuprofen did not differ, both of which were approximately 2 hours. Oral ibuprofen was 100% bioavailable; therefore, the area under the concentration-time curve did not differ between i.v. and oral ibuprofen. In addition, i.v. ibuprofen infused over five to seven minutes did not differ in terms of safety or tolerability when compared with oral ibuprofen.
I.V. ibuprofen, when administered over five to seven minutes in healthy subjects, achieved a higher C(max) and a more-rapid t(max) than did oral ibuprofen and was found to be safe and well tolerated.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>21164065</pmid><doi>10.2146/ajhp100120</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1079-2082 |
ispartof | American journal of health-system pharmacy, 2011-01, Vol.68 (1), p.47-51 |
issn | 1079-2082 1535-2900 |
language | eng |
recordid | cdi_proquest_miscellaneous_818644592 |
source | Oxford Journals Online |
subjects | Administration, Oral Adult Anti-Inflammatory Agents, Non-Steroidal - administration & dosage Anti-Inflammatory Agents, Non-Steroidal - adverse effects Anti-Inflammatory Agents, Non-Steroidal - blood Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics Cross-Over Studies Dosage and administration Double-Blind Method Drug tolerance Female Gas Chromatography-Mass Spectrometry Half-Life Humans Ibuprofen Ibuprofen - administration & dosage Ibuprofen - adverse effects Ibuprofen - blood Ibuprofen - pharmacokinetics Infusions, Intravenous Male Pharmacokinetics |
title | Pharmacokinetics, safety, and tolerability of a rapid infusion of i.v. ibuprofen in healthy adults |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T03%3A19%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacokinetics,%20safety,%20and%20tolerability%20of%20a%20rapid%20infusion%20of%20i.v.%20ibuprofen%20in%20healthy%20adults&rft.jtitle=American%20journal%20of%20health-system%20pharmacy&rft.au=Pavliv,%20Leo&rft.date=2011-01-01&rft.volume=68&rft.issue=1&rft.spage=47&rft.epage=51&rft.pages=47-51&rft.issn=1079-2082&rft.eissn=1535-2900&rft_id=info:doi/10.2146/ajhp100120&rft_dat=%3Cgale_proqu%3EA249137908%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c353t-58e2fa6d7a17f8ca2c0ca888c214a7721f792ad81b54ca0ef6bcbdb8b72c74e33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=818644592&rft_id=info:pmid/21164065&rft_galeid=A249137908&rfr_iscdi=true |